HCL Technologies and Oracle forge a healthcare partnership

In order to reduce the time and cost of drug development, the country's third largest software services firm HCL Technologies has struck a partnership with Oracle Health Sciences to help life sciences companies execute and scale the next generation of digital clinical trials.

Shrikanth Shetty, Executive Vice President and North America Business Head for Life Sciences and Healthcare at HCL, said, “Although many of our customers have already established a strong case for leveraging mHealth technologies in clinical trials or digital therapies through proof of concept, we still see a chasm between the potential and actual adoption at scale."

The partnership will include the availability of HCL’s Faster Intelligent Trials (FIT) Solution using Oracle Health Sciences Mobile Health (mHealth) Connector Cloud Service (Oracle mHealth Cloud).


Jim Streeter, Global Vice President, Product Strategy, for Oracle Health Sciences said, “The life sciences industry has a great opportunity to radically change the way we understand and interact with patients during clinical trials. The collaboration between Oracle Health Sciences and HCL enables clinical teams to establish digitally enabled clinical trial processes and new digital trial methods such as remote patient monitoring. This is a very exciting time for the pharma industry as new technologies such as mHealth continue to accelerate clinical trials and speed time to market for patients who are waiting.”